frovatriptan

Known as: 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole, frovatriptan [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND Migraine headaches are a significant problem for American women with many of them suffering from headaches around the… (More)
Is this relevant?
2010
2010
The objective of this study is to assess patients’ satisfaction with migraine treatment with frovatriptan (F) or zolmitriptan (Z… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2009
2009
The efficacy of a 6-day regimen of frovatriptan for menstrual migraine (MM; attacks starting on day -2 to +3 of menses… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
Efficacy of 5-day treatment with oral frovatriptan 2.5 mg/die for the prophylaxis of post-dural puncture headache (PDPH) was… (More)
Is this relevant?
2007
2007
Acute treatment of menstrual migraine (MM) attacks is often incomplete and unsatisfactory, and perimenstrual prophylaxis with… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Menstrually associated migraine (MAM) is often prolonged and difficult to manage with conventional therapies… (More)
Is this relevant?
2004
2004
Cluster headaches both episodic and chronic are some of the most challenging headaches to treat. Although effective treatments… (More)
Is this relevant?
2002
2002
OBJECTIVE To confirm the clinical efficacy of frovatriptan 2.5 mg. BACKGROUND Frovatriptan is a new 5-hydroxytryptamine (5-HT… (More)
Is this relevant?
2002
2002
OBJECTIVE To determine the optimum dose of frovatriptan for the acute treatment of migraine. BACKGROUND Frovatriptan is a new… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND The triptans, selective serotonin 5-HT(1B/1D) agonists, are very effective acute migraine drugs with a well- developed… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?